Logo image of ALKLK.PA

KERLINK (ALKLK.PA) Stock Fundamental Analysis

EPA:ALKLK - Euronext Paris - Matif - FR0013156007 - Common Stock - Currency: EUR

0.57  -0.03 (-5.32%)

Fundamental Rating

2

Overall ALKLK gets a fundamental rating of 2 out of 10. We evaluated ALKLK against 26 industry peers in the Communications Equipment industry. ALKLK has a bad profitability rating. Also its financial health evaluation is rather negative. ALKLK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALKLK had negative earnings in the past year.
In the past year ALKLK had a positive cash flow from operations.
In the past 5 years ALKLK always reported negative net income.
In the past 5 years ALKLK reported 4 times negative operating cash flow.
ALKLK.PA Yearly Net Income VS EBIT VS OCF VS FCFALKLK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -16.13%, ALKLK is doing worse than 80.77% of the companies in the same industry.
The Return On Equity of ALKLK (-67.00%) is worse than 80.77% of its industry peers.
Industry RankSector Rank
ROA -16.13%
ROE -67%
ROIC N/A
ROA(3y)-10.75%
ROA(5y)-20.24%
ROE(3y)-32.94%
ROE(5y)-52.79%
ROIC(3y)N/A
ROIC(5y)N/A
ALKLK.PA Yearly ROA, ROE, ROICALKLK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300 -400

1.3 Margins

The Gross Margin of ALKLK (29.27%) is worse than 84.62% of its industry peers.
ALKLK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALKLK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.65%
GM growth 5Y-2.6%
ALKLK.PA Yearly Profit, Operating, Gross MarginsALKLK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

3

2. Health

2.1 Basic Checks

ALKLK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALKLK has more shares outstanding
Compared to 5 years ago, ALKLK has more shares outstanding
The debt/assets ratio for ALKLK is higher compared to a year ago.
ALKLK.PA Yearly Shares OutstandingALKLK.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALKLK.PA Yearly Total Debt VS Total AssetsALKLK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 1.11, we must say that ALKLK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.11, ALKLK is doing worse than 61.54% of the companies in the same industry.
ALKLK has a debt to FCF ratio of 4.96. This is a neutral value as ALKLK would need 4.96 years to pay back of all of its debts.
ALKLK's Debt to FCF ratio of 4.96 is in line compared to the rest of the industry. ALKLK outperforms 53.85% of its industry peers.
A Debt/Equity ratio of 1.74 is on the high side and indicates that ALKLK has dependencies on debt financing.
ALKLK's Debt to Equity ratio of 1.74 is on the low side compared to the rest of the industry. ALKLK is outperformed by 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.74
Debt/FCF 4.96
Altman-Z 1.11
ROIC/WACCN/A
WACC3.47%
ALKLK.PA Yearly LT Debt VS Equity VS FCFALKLK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

ALKLK has a Current Ratio of 2.60. This indicates that ALKLK is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.60, ALKLK is doing good in the industry, outperforming 73.08% of the companies in the same industry.
A Quick Ratio of 1.12 indicates that ALKLK should not have too much problems paying its short term obligations.
ALKLK has a Quick ratio of 1.12. This is in the lower half of the industry: ALKLK underperforms 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 1.12
ALKLK.PA Yearly Current Assets VS Current LiabilitesALKLK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.03% over the past year.
ALKLK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.87%.
The Revenue has been decreasing by -4.29% on average over the past years.
EPS 1Y (TTM)13.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.89%
Revenue 1Y (TTM)-13.87%
Revenue growth 3Y7.01%
Revenue growth 5Y-4.29%
Sales Q2Q%-5.71%

3.2 Future

Based on estimates for the next years, ALKLK will show a very strong growth in Earnings Per Share. The EPS will grow by 27.13% on average per year.
ALKLK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.85% yearly.
EPS Next Y-5.45%
EPS Next 2Y15.99%
EPS Next 3Y27.13%
EPS Next 5YN/A
Revenue Next Year-14.6%
Revenue Next 2Y8.07%
Revenue Next 3Y18.85%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALKLK.PA Yearly Revenue VS EstimatesALKLK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
ALKLK.PA Yearly EPS VS EstimatesALKLK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALKLK. In the last year negative earnings were reported.
Also next year ALKLK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALKLK.PA Price Earnings VS Forward Price EarningsALKLK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALKLK indicates a rather cheap valuation: ALKLK is cheaper than 96.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.61
EV/EBITDA N/A
ALKLK.PA Per share dataALKLK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

ALKLK's earnings are expected to grow with 27.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.99%
EPS Next 3Y27.13%

More info and screens

0

5. Dividend

5.1 Amount

ALKLK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KERLINK

EPA:ALKLK (3/7/2025, 7:00:00 PM)

0.57

-0.03 (-5.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A N/A
Earnings (Next)04-24 2025-04-24/amc
Inst Owners13.2%
Inst Owner ChangeN/A
Ins Owners5.6%
Ins Owner ChangeN/A
Market Cap4.26M
Analysts40
Price Target1.12 (96.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.73%
EPS NY rev (3m)-13.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-9.3%
Revenue NY rev (3m)-9.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF 1.61
P/OCF 1.05
P/B 0.72
P/tB 1.44
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)0.35
FCFY62.21%
OCF(TTM)0.54
OCFY94.88%
SpS1.78
BVpS0.79
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.13%
ROE -67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.27%
FCFM 19.88%
ROA(3y)-10.75%
ROA(5y)-20.24%
ROE(3y)-32.94%
ROE(5y)-52.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.65%
GM growth 5Y-2.6%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.74
Debt/FCF 4.96
Debt/EBITDA N/A
Cap/Depr 70.93%
Cap/Sales 10.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.6
Quick Ratio 1.12
Altman-Z 1.11
F-Score5
WACC3.47%
ROIC/WACCN/A
Cap/Depr(3y)104.46%
Cap/Depr(5y)73.11%
Cap/Sales(3y)10.66%
Cap/Sales(5y)9.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.89%
EPS Next Y-5.45%
EPS Next 2Y15.99%
EPS Next 3Y27.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.87%
Revenue growth 3Y7.01%
Revenue growth 5Y-4.29%
Sales Q2Q%-5.71%
Revenue Next Year-14.6%
Revenue Next 2Y8.07%
Revenue Next 3Y18.85%
Revenue Next 5YN/A
EBIT growth 1Y31.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.71%
EBIT Next 3Y38.01%
EBIT Next 5YN/A
FCF growth 1Y124.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y148.5%
OCF growth 3YN/A
OCF growth 5Y60.59%